Seizert Capital Partners’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-97,906
Closed -$4.69M 216
2022
Q1
$4.69M Buy
97,906
+77
+0.1% +$3.82K 0.22% 74
2021
Q4
$4.96M Buy
97,829
+1,801
+2% +$80.1K 0.22% 76
2021
Q3
$3.89M Buy
96,028
+6,877
+8% +$348K 0.18% 90
2021
Q2
$5.05M Buy
89,151
+12,585
+16% +$716K 0.24% 72
2021
Q1
$4.05M Buy
76,566
+37,337
+95% +$2.03M 0.21% 73
2020
Q4
$2.14M Sell
39,229
-2,157
-5% -$114K 0.12% 77
2020
Q3
$2.07M Sell
41,386
-4,379
-10% -$208K 0.14% 72
2020
Q2
$1.75M Sell
45,765
-28,312
-38% -$910K 0.12% 80
2020
Q1
$1.62M Buy
74,077
+42,604
+135% +$1.28M 0.12% 80
2019
Q4
$1.29M Buy
+31,473
New +$1.28M 0.06% 120

Other funds holding NUS

Seizert Capital Partners's NUS Position: Q2 2022 in Review

Seizert Capital Partners sold out of Nu Skin (NUS) in Q2 2022, closing a stake of 97,906 shares — an estimated $4.69M sold.

Seizert Capital Partners first reported a position in NUS in Q4 2019 and held it in 10 quarters. The position peaked at $5.05M in Q2 2021. 222 funds tracked by Wall St. Rank hold NUS as of Q2 2022.

  • Seizert Capital Partners reported no remaining Nu Skin position as of Q2 2022 after selling out during the quarter.
  • Seizert Capital Partners sold 97,906 Nu Skin shares in Q2 2022, an estimated $4.69M.
  • Seizert Capital Partners first reported a position in Nu Skin in Q4 2019 and held it in 10 quarters.
  • Seizert Capital Partners's Nu Skin position peaked at $5.05M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held Nu Skin as of Q2 2022.

Based on Seizert Capital Partners's 13F filing for Q2 2022, filed 4 Aug 2022.